Immune research
Thymosin Alpha-1
Lyophilized immune-signaling research peptide for pathway review
Thymosin Alpha-1 is an immune-signaling research peptide studied in T-cell, dendritic-cell, and cytokine-network literature.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesSomente para uso em pesquisa laboratorial. Não é para uso humano ou veterinário. Não se destina a diagnosticar, tratar, curar, mitigar ou prevenir doenças.
Mantenha selado, frio, seco e protegido de oscilações de calor. Confirme o armazenamento específico do produto na chegada.
Embalado para estabilidade de trânsito com suporte para pedidos disponível para rotas em clima quente.
Batch-linked certificate support is available through the documentation desk.
Contexto de pesquisa
Perfil de pesquisa de Thymosin Alpha-1
Thymosin Alpha-1 is a 28-amino-acid peptide studied in immune regulation and host-response biology. Research examines T-cell differentiation and function, dendritic-cell activity, Toll-like-receptor signaling, cytokine patterns, innate and adaptive immune responses, and interactions with infectious or inflammatory model systems. It differs from thymosin beta-4-related materials such as TB-500, which are studied more often in actin, migration, and tissue-remodeling contexts. Thymosin Alpha-1 is selected when the experimental design specifically requires this immune-signaling peptide. Clinical literature exists for regulated thymalfasin products in some regions, but that does not establish equivalence, approval, or performance of a catalog batch.
Molecular class
28-residue thymic peptide
Sequence / composition
An acetylated 28-amino-acid peptide corresponding to the amino-terminal region of prothymosin alpha.
Research design note
Its defined length and N-terminal acetylation distinguish it from thymosin beta-4-related materials.
Mecanismo proposto
A 28-amino-acid thymic peptide proposed to modulate innate and adaptive immunity through dendritic-cell and T-cell maturation, Toll-like-receptor-related signaling, cytokine production, antigen presentation, and restoration of immune responsiveness.
Efeitos relatados em estudos
- Cell and animal studies report changes in dendritic-cell function, T-cell activity, cytokine profiles, and innate immune responses.
- Clinical studies of regulated thymalfasin products report immune and infection-related outcomes in selected diseases and treatment combinations.
- Results vary by disease, immune state, co-therapy, and study quality; broad immune-enhancement claims are not justified.
Desfechos comuns de pesquisa
T-cell subsets and function, dendritic-cell maturation, Toll-like-receptor signaling, cytokines, antigen presentation, viral or microbial measures, clinical outcomes, and adverse events.
Evidências e limitações
Mechanistic, preclinical, and human clinical literature exists for thymalfasin in some jurisdictions. It does not establish equivalence of a catalog material.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
Where can I find product documentation?
Contact support with the product name and any relevant order or batch reference to request available documents.
How can I compare pack options?
Where multiple pack sizes are available, Azure shows the price per listed vial so you can compare catalog value directly.